No single definition of cytokine storm or the cytokine release syndrome is widely accepted, and there is disagreement about how these disorders differ from an appropriate inflammatory response. The ...
Blueprint Medicines BPMC announced positive top-line results from the Part 2 of PIONEER clinical trial of AYVAKIT (avapritinib) in patients with non-advanced systemic mastocytosis (SM). The Part 2 of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback